Current research to overcome T-cell dysfunction in CLL and improve therapies
What impact do side effects have on elderly chronic myeloid leukemia (CML) patients?
Molecular genetics and targeting in AML: highlights from ASH 2017
MRD negativity and its role as a predictor for CLL patient responses
Encouraging data from the RAY trial 3-year follow-up